Dow Down 0.92% Nasdaq Down 0.83%

AbbVie Inc. (ABBV)

-NYSE
56.90 Up 0.61(1.08%) 4:01PM EDT
|After Hours : 56.81 Down 0.09 (0.16%) 6:52PM EDT
Prev Close:56.29
Open:56.96
Bid:56.80 x 500
Ask:57.45 x 300
1y Target Est:63.70
Beta:1.928
Next Earnings Date:31-Oct-14ABBV Earnings announcement
Day's Range:56.26 - 57.45
52wk Range:45.50 - 60.02
Volume:16,048,709
Avg Vol (3m):14,248,800
Market Cap:90.57B
P/E (ttm):22.05
EPS (ttm):2.58
Div & Yield:1.68 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.08%90.57B
MRKUp 0.69%160.13B
NVSDown 0.46%213.99B
PFEUp 0.07%179.45B

Key Statistics

Forward P/E (1 yr):14.66
P/S (ttm):4.65
Ex-Dividend Date:10-Oct-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback